- Palantir gains 500% in a year as AI tailwinds fuel explosive investor optimism.
- UnitedHealth sinks 47% in a month alone, amid regulatory heat, dragging healthcare sector to worst relative underperformance in 24 years.
- Get ahead of Wall Street reactions—Benzinga Pro delivers signals, squawk, and news fast. Now 60% off this 4th of July.
In a market where healthcare stocks are facing their worst month in 24 years, Palantir Technologies Inc PLTR is stealing the spotlight, soaring over 32% in the past month and a staggering 500% over the past year.
Meanwhile, UnitedHealth Group Inc UNH, the healthcare giant, has been hammered—down over 40% over the past year and 47% in the last month alone, dragged by a suspended 2025 outlook and CEO Andrew Witty's unexpected departure.
Palantir's AI-Powered Rocket Ride
Palantir's free cash flow last year hit $1.3 billion, backing a $300 billion market cap that investors are rewarding amid the AI revolution.
The company's cutting-edge analytics software has secured growing contracts from both government and commercial clients, fueling revenue growth of 50% over the past two years.
Riding the tech wave, clocking gains of over 32% over the past month alone, Palantir stock has outperformed the broader S&P 500-tracking SPDR S&P 500 ETF SPY and tech-heavy Technology Select Sector SPDR Fund XLK, which gained 9% and 17%, respectively.
UnitedHealth's Rocky Road
By contrast, UnitedHealth's free cash flow dwarfs Palantir's at $25 billion, but its $285 billion market cap reflects investor concerns.
Regulatory pressures, rising costs, and antitrust scrutiny have spooked shareholders, dragging down the entire Health Care Select Sector SPDR Fund XLV. In a month when the S&P 500 climbed 9%, the fund dropped 7%.
UnitedHealth's troubles underline the broader healthcare sector's struggles, lagging the market by the largest margin in over two decades.
The story here is clear. While healthcare faces mounting headwinds, AI-driven tech stocks like Palantir are powering ahead, rewriting the rules of growth and value in 2025's stock market.
Read Next:
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.